NorDiag enters distribution and collaboration agreement with Molzym

22-Oct-2008 - Canada

NorDiag has entered into two distribution agreements with German based Molzym GmbH & Co KG covering Molzym’s molecular diagnostic products. The first agreement is geographically restrained to USA and Canada, while the second agreement covers the Nordic countries.

NorDiag has also entered into a collaboration agreement with Molzym, primarily with the purpose of integrating NorDiag’s magnetic bead based sample preparation chemistry and low throughput automation platform with Molzym’s molecular diagnostic products among others their SepsiTest™.

“We have chosen NorDiag due to their geographic presence, competence and position in the clinical diagnostic market”, says Molzym CEO Jan Detmers.

“Growing revenues by taking in complementary products is a key element in our strategy going forward and the agreements with Molzym will be an important contributor in increasing volumes. We also intend to offer an OEM agreement for NorDiag’s products to Molzym, which will open for cross-sales and further increase revenues” says NorDiag CEO Mårten Wigstøl.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances